March 2026 Cosmetic Regulatory Update | UK, EU, US & Canada
Regulatory pressure on the cosmetics industry is no longer cyclical—it’s continuous. March 2026 highlights a clear shift toward tighter ingredient controls, lower labelling thresholds, and increased enforcement across all major markets. At the same time, divergence between regions is accelerating, making global compliance more complex than ever.
Here’s what matters 👇
🇪🇺 EU: CMR Omnibus & Environmental Pressure
The EU continues to lead on ingredient regulation with:
- Regulation (EU) 2026/78 (CMR Omnibus), effective May 2026
• Ongoing SCCS-driven ingredient restrictions
• Increasing scrutiny on persistent substances (e.g. PFAS)
• Alignment with broader environmental policy
👉 Why it matters:
Regulatory change is accelerating, with automatic links between hazard classification and cosmetic bans. Future-proofing formulations is becoming essential.
🇬🇧 UK: Ingredient Restrictions & Labelling Tighten
The latest UK amendments introduce:
- A ban on 4-MBC (enzacamene) in suncare (July 2026)
• Expanded CMR substance restrictions
• A reduced formaldehyde labelling threshold (≥0.001%)
• Formulation transition and market withdrawal timelines are becoming more defined
👉 Why it matters:
Formulations previously considered compliant may now require reformulation or updated labelling—particularly preserved systems and legacy raw materials.
🇺🇸 US: MoCRA Moves Into Enforcement Phase
The US regulatory landscape is evolving rapidly:
- Mandatory facility registration and product listing
• Expanded FDA inspection and recall powers
• Greater focus on safety substantiation
• Growing complexity from state-level requirements
👉 Why it matters:
The US is shifting from a light-touch system to a structured regulatory framework—raising the bar for documentation and compliance.
🇨🇦 Canada: Gradual Alignment with EU Standards
Canada continues to strengthen its approach:
- Ongoing Cosmetic Ingredient Hotlist updates
• Mandatory CNF submission within 10 days
• Increased focus on bilingual labelling
• Movement toward expanded allergen disclosure
👉 Why it matters:
While less prescriptive, Canada is becoming more aligned with EU expectations—particularly around transparency and classification.
🔍 Key Watchlist for Formulators
Across all regions, increased scrutiny is being placed on:
- UV filters
• Photoinitiators (e.g. TPO)
• Formaldehyde-releasing preservatives
• Persistent environmental contaminants (e.g. PFAS)
📅 Key Dates to Watch
- May 2026 (EU) – CMR Omnibus applies
• July 2026 (UK) – 4-MBC ban comes into force
• 2026–2027 – Transition and sell-through periods
💡 ADSL Perspective
The regulatory landscape is becoming more dynamic, more fragmented, and more technically demanding.
Key risks for brands and manufacturers include:
- Formulation obsolescence
• Labelling non-compliance
• Multi-market complexity
• Increased scrutiny on safety data
At ADSL, we support clients across:
- Reformulation and compliance strategy
• Safety assessments (CPSR)
• Ingredient and formulation validation
• Labelling and claims substantiation
• Regulatory documentation
As regulatory expectations continue to evolve, early alignment between formulation, safety, and regulatory teams is critical to maintaining market access.
ADSL – Advanced Development & Safety Laboratories
Technical Team | Paignton, UK
